BRPI0913983A2 - composição cosmética e/ou terapêutica, e, método para fabricar um produto para cuidado da pele tópico - Google Patents

composição cosmética e/ou terapêutica, e, método para fabricar um produto para cuidado da pele tópico

Info

Publication number
BRPI0913983A2
BRPI0913983A2 BRPI0913983A BRPI0913983A BRPI0913983A2 BR PI0913983 A2 BRPI0913983 A2 BR PI0913983A2 BR PI0913983 A BRPI0913983 A BR PI0913983A BR PI0913983 A BRPI0913983 A BR PI0913983A BR PI0913983 A2 BRPI0913983 A2 BR PI0913983A2
Authority
BR
Brazil
Prior art keywords
cosmetic
making
skin care
therapeutic composition
care product
Prior art date
Application number
BRPI0913983A
Other languages
English (en)
Inventor
Bjorn Larus Orvar
Einar Mantyla
Original Assignee
Orf Liftaekni Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orf Liftaekni Hf filed Critical Orf Liftaekni Hf
Publication of BRPI0913983A2 publication Critical patent/BRPI0913983A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI0913983A 2008-06-30 2009-06-30 composição cosmética e/ou terapêutica, e, método para fabricar um produto para cuidado da pele tópico BRPI0913983A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS8741 2008-06-30
IS8764 2008-10-09
PCT/IS2009/000003 WO2010001417A2 (en) 2008-06-30 2009-06-30 Use of plant-derived recombinant growth factors in skin care

Publications (1)

Publication Number Publication Date
BRPI0913983A2 true BRPI0913983A2 (pt) 2015-10-20

Family

ID=41226629

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913983A BRPI0913983A2 (pt) 2008-06-30 2009-06-30 composição cosmética e/ou terapêutica, e, método para fabricar um produto para cuidado da pele tópico

Country Status (12)

Country Link
US (1) US20110195112A1 (pt)
EP (1) EP2309975A2 (pt)
JP (1) JP2011526623A (pt)
KR (1) KR20110092265A (pt)
CN (1) CN102307561A (pt)
AU (1) AU2009265103A1 (pt)
BR (1) BRPI0913983A2 (pt)
CA (1) CA2729382A1 (pt)
MX (1) MX2011000047A (pt)
RU (1) RU2011103200A (pt)
SG (1) SG193139A1 (pt)
WO (1) WO2010001417A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013005234A1 (en) * 2011-07-06 2013-01-10 Orf Liftaekni Hf Therapeutic use of stabilised factor for dermatological conditions
EP2729219A4 (en) * 2011-07-06 2015-04-01 Orf Líftaekni Hf METHOD OF USING NON-VEGETABLE GROWTH FACTOR STABILIZED FOR SKIN CARE
US20140066837A1 (en) 2012-07-26 2014-03-06 Ronald L. Moy Skin care compositions and methods
KR20150133222A (ko) * 2013-03-13 2015-11-27 스테메트릭스, 인코포레이티드. 피부 조성물 및 피부 조성물의 용도
WO2015003254A1 (en) * 2013-07-11 2015-01-15 Exerkine Corporation Therapeutic method of inducing mitochondrial biogenesis
JP6159183B2 (ja) * 2013-07-23 2017-07-05 日本メナード化粧品株式会社 幹細胞由来成長因子産生促進剤
CN103550126A (zh) * 2013-11-08 2014-02-05 王洪博 一种生物祛痘淡痕修复乳
CN103690393B (zh) * 2013-12-30 2016-07-13 广东丽姿生物科技有限公司 美白抗皱生物蚕丝面膜
CN103705394B (zh) * 2013-12-30 2016-03-23 广东丽姿生物科技有限公司 祛痘消痕生物蚕丝面膜
WO2015118069A1 (en) * 2014-02-05 2015-08-13 Reponex Pharmaceuticals Aps Compositions to promote the healing of skin ulcers and wounds
CA2940494C (en) 2014-03-14 2022-11-08 Gojo Industries, Inc. Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines
CN103976908B (zh) * 2014-05-29 2016-04-27 暨南大学 一种富含植物多肽的植物提取物组合物及其在化妆品中的应用
WO2015197877A1 (es) * 2014-06-24 2015-12-30 Dermopartners, S.L. Producto cosmetico con factores de crecimiento liposomados
CN104622713B (zh) * 2015-01-26 2017-07-14 杭州易文赛生物技术有限公司 一种化妆品组合物及其制备方法
JP6522387B2 (ja) * 2015-03-27 2019-05-29 株式会社キレートジャパン ハイドロゲル含有化粧料
WO2017027806A1 (en) 2015-08-13 2017-02-16 Coty Inc. Formulation and method for promoting cutaneous uptake of molecular oxygen by skin
WO2018015973A1 (en) * 2016-07-21 2018-01-25 Khorakiwala Habil F Topical pharmaceutical composition for promoting hair growth and/or reducing hair loss
KR101951283B1 (ko) * 2017-11-13 2019-02-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
CN108498385A (zh) * 2018-04-28 2018-09-07 广州赛莱拉干细胞科技股份有限公司 含有软毛松藻提取物的组合物及其在化妆品的应用
KR102083081B1 (ko) * 2018-05-30 2020-02-28 연세대학교 산학협력단 유데나필을 유효성분으로 포함하는 지방줄기세포의 발모 유도능 증진용 조성물
CN111269303A (zh) * 2020-02-14 2020-06-12 中国农业大学 蛋白质IbEGF及其相关生物材料和应用
KR102364823B1 (ko) * 2020-05-06 2022-02-21 연세대학교 산학협력단 피부 세포 재생용 화장료 조성물
US20230220027A1 (en) * 2020-06-05 2023-07-13 Orf Liftaekni Hf Growth factor composition for cell culture-produced meat

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5618544A (en) * 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US7361331B2 (en) * 1996-10-18 2008-04-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Plant bioreactors
BR9915919A (pt) * 1998-10-07 2001-08-21 Syngenta Participations Ag Proteìnas terapeuticamente ativas em plantas
KR100377397B1 (ko) * 1999-12-23 2003-03-26 주식회사 대웅 레티놀 및 표피성장인자를 함유하는 피부보호 화장료 조성물
US20040078851A1 (en) * 2000-05-02 2004-04-22 Ning Huang Production of human growth factors in monocot seeds
JP2002209462A (ja) * 2000-12-26 2002-07-30 Academia Sinica トランスジェニック植物種子におけるタンパク質産生
JP2004528022A (ja) * 2001-02-14 2004-09-16 ベントリア バイオサイエンス トランスジェニック植物におけるヒト乳タンパク質の発現
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
CN101172091B (zh) * 2007-09-25 2011-04-27 北京美福源生物医药科技有限公司 含人血清白蛋白与皮肤细胞生长因子的融合蛋白护肤产品制备工艺和用途
WO2004005520A1 (en) * 2002-07-03 2004-01-15 Nexgen Biotechnologies, Inc. Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants
JP2007503211A (ja) * 2003-08-27 2007-02-22 オーアールエフ・リフタエクニ・エイチエフ 植物から組換えタンパク質を精製するための非変性プロセス

Also Published As

Publication number Publication date
JP2011526623A (ja) 2011-10-13
WO2010001417A3 (en) 2011-10-13
EP2309975A2 (en) 2011-04-20
WO2010001417A2 (en) 2010-01-07
US20110195112A1 (en) 2011-08-11
CA2729382A1 (en) 2010-01-07
CN102307561A (zh) 2012-01-04
SG193139A1 (en) 2013-09-30
RU2011103200A (ru) 2012-08-10
MX2011000047A (es) 2011-06-16
AU2009265103A1 (en) 2010-01-07
KR20110092265A (ko) 2011-08-17

Similar Documents

Publication Publication Date Title
BRPI0909251A2 (pt) Composição para o cuidado da pele
BRPI0821690A2 (pt) Composição cosmética e método para obscurecer oticamente a aparência das imperfeições da pele
BRPI0716592A2 (pt) Composição para cuidado da pele
BRPI0811273A2 (pt) Composição anti-envelhecimento para cuidado da pele, e, método de tratamento cosmético da pele
BRPI1006024B8 (pt) composição cosmética emulsificada para cuidado da pele
BRPI0910874A2 (pt) composições e métodos para cuidado da pele
BRPI0920043A2 (pt) sistema cosméticos ou dermatológico, e, método para dispensar um rpoduto cosmético pu para pele
BRPI0916036A2 (pt) método cosmético para tratar a perspiração humana, composição e composição sólida anidra
BRPI0923662A2 (pt) composições tópicas contendo melicope hayesii e um método para o tratamento da pele
BRPI0716671A2 (pt) Produto semi-acabado na fabricação de uma composição para cuidado da pele ou do cabelo
BRPI0814776A2 (pt) Método para manter consistência para tratamentos de distribuição de droga em aerossol, e, aparelho para distribuição de droga em aerossol
BR112013014583A2 (pt) composição farmacêutica, e, métodos para o tratamento de inflamação, para o tratamento da dor, e para preparar 3-metanossulfonilpropionitrila
BR112013012586A2 (pt) composição cosmética para o branqueamento da pele compreendendo resveratrol
BR112013011894A2 (pt) hidrolisado de colágeno para usar para melhorar a saúde da pele humana, cabelos e/ou unhas
BRPI0821814A2 (pt) Uso e formulação tópica de eritropoietina para a cicatrização da pele
BR112012004451A2 (pt) formulações para o cuidado com a pele"
BRPI0907102A2 (pt) composição dental, e, método para eliminar ou reduzir o desconforto e a dor associados com a hipersensibilidade da dentina
WO2013025765A3 (en) Methods of reducing odor
BR112013001709A2 (pt) apareçhp para a avaliação do estado da pele ou do cabelo
BRPI0919316A2 (pt) sistema comestico ou dermatologico, e, metodo para tratar cosmeticamente pele ou cabelo
BR112015014497A2 (pt) composição cosmética, método para aprimorar a característica de pele e utilização da composição.
BRPI1014488A2 (pt) composições adequadas para o tratamento tópico de infecções fúngicas da pele e das unhas
BR112014000318A2 (pt) composição, uso cosmético não terapêutico e método não terapêutico de cuidado com a pele e/ou de maquiagem
BRPI0810948A2 (pt) "composição hidratante, usos da composição e método para hidratar ou umidificar a pele"
BRPI1012263A2 (pt) complexo clarificante de pele, uso do referido complexo, composição cosmética ou farmacêutica compreendendo o referido complexo e método de aplicação do mesmo.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]